TYMS and neoplasm: In addition to modulating DNA promoter methylation, pyrimidine analog DNMT inhibitors can yield tumor DNA damage and subsequent cell cycle arrest and cell death via their conversion to 2′-deoxyuridine 5′-monophosphate (dUMP) analogs that inhibit thymidylate synthase (TS) [46].